Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein
about
EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replicationAn Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 linkIRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latencyInterferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytesDual functions of interferon regulatory factors 7C in Epstein-Barr virus-mediated transformation of human B lymphocytesGlobal transcript structure resolution of high gene density genomes through multi-platform data integrationEpstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expressionMechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.CTCF prevents the epigenetic drift of EBV latency promoter QpEpigenetic regulation of EBV persistence and oncogenesis.The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitiveEstablishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID miceFunctional analyses of the EBNA1 origin DNA binding protein of Epstein-Barr virus.Repression of Epstein-Barr virus EBNA-1 gene transcription by pRb during restricted latencyInterferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1.Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virusLinkage between STAT regulation and Epstein-Barr virus gene expression in tumors.Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency.EBV latency types adopt alternative chromatin conformations.The expression and function of Epstein-Barr virus encoded latent genesEpstein-Barr virus nuclear antigen 3A promotes cellular proliferation by repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1.Toll-like receptor 7 stimulates the expression of Epstein-Barr virus latent membrane protein 1Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation.Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA.Epstein-Barr virus activates beta-catenin in type III latently infected B lymphocyte lines: association with deubiquitinating enzymesInterferon regulatory factor 4 (IRF-4) targets IRF-5 to regulate Epstein-Barr virus transformation.Gene expression profiling identifies IRF4-associated molecular signatures in hematological malignanciestrans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency.The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activityActivation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F.A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycleThe Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element.Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma.The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cellsThe cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuliImmunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection.Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programsEpstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.
P2860
Q21131571-51BCB89A-322A-435B-8B27-7B5BB387D9F7Q21131584-9C97CFE9-DF71-48BC-A77D-8E91BB345730Q24315695-0091A57D-D750-4398-8F81-C66999ADBE08Q24646670-C1E4CC6D-198C-4E7C-B5A1-E38375EA0403Q30979226-7BA82876-597E-4BD3-99E2-BE446C97F6C7Q31114225-982373B8-B020-4E33-8A9E-EF5FA4059A23Q33641167-9E052515-F29C-40D9-B52C-5E40EBDB9517Q33653017-5BD9A73B-6709-44C9-A53E-536D3A9DDC6FQ33668727-19BD06F4-3691-4444-8607-96BA981D3444Q33723664-90A6E669-F478-4547-B609-FFF02A8A2708Q33783746-CB231D7A-40B4-45F2-B18F-8EB9B4E81465Q33784983-1FB8FA86-8514-400A-ACCD-1ACED3B38CB6Q33787020-C5C5BBEE-74B6-47EC-A23D-CFF8090D49DBQ33818658-607BE4EB-C812-430C-B538-76A1F1C3995DQ33834888-9CBAB4FE-6F88-4C7D-94DB-7D8864922C4CQ33865166-A3029C15-EDE3-4ACA-92F9-AD01F6CDC245Q33866046-852671DB-C249-4E1E-8DDC-3C9520D5101EQ33957851-2D359A2A-E62E-401B-A10D-244196C7820BQ33987454-B81048C0-0F4E-4EDC-9A9C-49CA3C129825Q34089485-8C3C5D2D-4933-4A5B-B800-90AF63816B0FQ34283174-D146F52B-D8A2-40EA-8BE9-80DB5A731C41Q34405076-121DF8AB-C22E-4F7F-9DEE-EBFCF339D492Q34485302-D74CA043-200D-480E-8C39-01F200C7BC9AQ34658852-8C2B32E8-3941-4A6E-81BA-B0002B782775Q34703035-A225C3B0-98AB-44BC-BA84-438826B9BC39Q34789389-8D7949F2-6716-415E-8714-148937FE70F5Q34979127-D11B447A-9827-48FD-AF1C-522CE1DBD257Q35245799-F58686F2-7973-4D0A-BE28-152012C61F1CQ35363296-0B82BB13-13D2-41CB-909D-7ABADDA452DAQ35603820-3E4E59A0-2B5B-49D1-8B87-43B88461EDA1Q35859223-68BB1CC5-EB04-4F62-AE78-82A7FE3B5C14Q35872919-983645F0-869D-4997-9238-3622CE0F12EFQ35874869-41051FDC-9593-4082-B043-1B0A7CBAB6A7Q35892261-EB4E809C-83BF-421D-A199-37C336D3C9D5Q36006767-80D0CF94-728B-4F75-A13D-56EE534F08FBQ36135900-A59F71C7-5B3E-4FB7-94DF-E0582B6B47D8Q36414572-7F62B594-3AFC-4909-8AA8-52810959FF21Q36498133-A5E08CB8-FCE7-4C05-9FFC-31A598EA120AQ36564877-E4FE0EBB-7191-40CE-AE0B-422FB889291FQ37595549-9E87FE5E-0C20-481C-BC1F-743934435513
P2860
Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Transcription start sites down ...... sion of the EBV EBNA-1 protein
@ast
Transcription start sites down ...... sion of the EBV EBNA-1 protein
@en
type
label
Transcription start sites down ...... sion of the EBV EBNA-1 protein
@ast
Transcription start sites down ...... sion of the EBV EBNA-1 protein
@en
prefLabel
Transcription start sites down ...... sion of the EBV EBNA-1 protein
@ast
Transcription start sites down ...... sion of the EBV EBNA-1 protein
@en
P2093
P2860
P1433
P1476
Transcription start sites down ...... sion of the EBV EBNA-1 protein
@en
P2093
P2860
P304
P407
P577
1996-01-01T00:00:00Z